Lysophospholipid receptors in drug discovery.
Experimental Cell Research, 2015 Y. Kihara, H. Mizuno, J. Chun
semanticscholar +1 more source
A Holistic Review of Oncological Drug Targets and Trajectories of Resistance in Cancer Therapy. [PDF]
Oncol ResKaur H, Rana D, Bag S, Singh P.
europepmc +1 more source
Muscarinic acetylcholine receptors: novel opportunities for drug development
Nature reviews. Drug discovery, 2014 A. Kruse +5 more
semanticscholar +1 more source
Cannabidiol-Ion Channel Interactions Represent a Promising Preventive and Therapeutic Strategy in Hepatocellular Carcinoma. [PDF]
PathophysiologyChávez-López MG +7 more
europepmc +1 more source
Chimeric Approach to Identify Molecular Determinants of Nicotinic Acetylcholine Receptors. [PDF]
Int J Mol SciSapkota P +3 more
europepmc +1 more source
Advances in Therapeutic Antibody Discovery and Development Targeting G Protein-Coupled Receptors. [PDF]
Pharmacol Res PerspectHutchings CJ +6 more
europepmc +1 more source
Molecular docking: a powerful approach for structure-based drug discovery.
Current Computer - Aided Drug Design, 2011 Xuanyu Meng +3 more
semanticscholar +1 more source
The assumption of a threshold is false in risk assessments for endocrine disrupting chemicals (EDCs) when endogenous hormones being disrupted are already above any possible threshold: a policy failure by the US FDA. [PDF]
Environ HealthSaal FSV, Welshons WV.
europepmc +1 more source
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.
Annual Review of Pharmacology and Toxicology, 2016 Jiabei Liu +5 more
semanticscholar +1 more source
The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior. [PDF]
Pharmacol RepKościuk Z +3 more
europepmc +1 more source